Ebit Perubahan Tanggal
AbbVie USD 4.73B 1.08B 2026-03
Agenus USD 14.4M 19.26M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Ardelyx USD 5.1M 2.02M 2025-12
aTyr Pharma USD 24.47M 24.7M 2025-12
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Celldex Therapeutics USD -84.44M 2.72M 2026-03
Curis USD -7.88M 4.31M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Incyte USD 344.17M 39.71M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Novartis USD 4.18B 118M 2026-03
Novartis USD 4.06B 413M 2025-12
Pfizer USD 4.99B 340M 2026-03
Prothena USD -27.21M 12.55M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Xoma USD -10.08M 4.4M 2024-06